Franklin Resources
CABA icon

Franklin Resources’s Cabaletta Bio CABA Stock Holding History

Franklin Resources’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,904
Closed -$141K – 2929
2024
Q2 		$141K Buy
18,904
+2,781
+17% +$34.1K ﹤0.01% 2628
2024
Q1 		$275K Buy
16,123
+4,058
+34% +$87.1K ﹤0.01% 2495
2023
Q4 		$274K Hold
12,065
– – ﹤0.01% 2221
2023
Q3 		$184K Buy
+12,065
New +$165K ﹤0.01% 2340

Other funds holding CABA

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Franklin Resources's CABA Position: Q3 2024 in Review

Franklin Resources sold out of Cabaletta Bio (CABA) in Q3 2024, closing a stake of 18,904 shares — an estimated $141K sold.

Franklin Resources first reported a position in CABA in Q3 2023 and held it in 4 quarters. The position peaked at $275K in Q1 2024. 120 funds tracked by Wall St. Rank hold CABA as of Q3 2024.

  • Franklin Resources reported no remaining Cabaletta Bio position as of Q3 2024 after selling out during the quarter.
  • Franklin Resources sold 18,904 Cabaletta Bio shares in Q3 2024, an estimated $141K.
  • Franklin Resources first reported a position in Cabaletta Bio in Q3 2023 and held it in 4 quarters.
  • Franklin Resources's Cabaletta Bio position peaked at $275K in Q1 2024.
  • 120 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2024.

Based on Franklin Resources's 13F filing for Q3 2024, filed 12 Nov 2024.